Impact of acute consumption of beverages containing plant-based or alternative sweetener blends on postprandial appetite, food intake, metabolism, and gastro-intestinal symptoms: Results of the SWEET beverages trial.


Journal

Appetite
ISSN: 1095-8304
Titre abrégé: Appetite
Pays: England
ID NLM: 8006808

Informations de publication

Date de publication:
01 05 2023
Historique:
received: 23 11 2022
revised: 24 02 2023
accepted: 24 02 2023
pubmed: 28 2 2023
medline: 22 3 2023
entrez: 27 2 2023
Statut: ppublish

Résumé

Project SWEET examined the barriers and facilitators to the use of non-nutritive sweeteners and sweetness enhancers (hereafter "S&SE") alongside potential risks/benefits for health and sustainability. The Beverages trial was a double-blind multi-centre, randomised crossover trial within SWEET evaluating the acute impact of three S&SE blends (plant-based and alternatives) vs. a sucrose control on glycaemic response, food intake, appetite sensations and safety after a carbohydrate-rich breakfast meal. The blends were: mogroside V and stevia RebM; stevia RebA and thaumatin; and sucralose and acesulfame-potassium (ace-K). At each 4 h visit, 60 healthy volunteers (53% male; all with overweight/obesity) consumed a 330 mL beverage with either an S&SE blend (0 kJ) or 8% sucrose (26 g, 442 kJ), shortly followed by a standardised breakfast (∼2600 or 1800 kJ with 77 or 51 g carbohydrates, depending on sex). All blends reduced the 2-h incremental area-under-the-curve (iAUC) for blood insulin (p < 0.001 in mixed-effects models), while the stevia RebA and sucralose blends reduced the glucose iAUC (p < 0.05) compared with sucrose. Post-prandial levels of triglycerides plus hepatic transaminases did not differ across conditions (p > 0.05 for all). Compared with sucrose, there was a 3% increase in LDL-cholesterol after stevia RebA-thaumatin (p < 0.001 in adjusted models); and a 2% decrease in HDL-cholesterol after sucralose-ace-K (p < 0.01). There was an impact of blend on fullness and desire to eat ratings (both p < 0.05) and sucralose-acesulfame K induced higher prospective intake vs sucrose (p < 0.001 in adjusted models), but changes were of a small magnitude and did not translate into energy intake differences over the next 24 h. Gastro-intestinal symptoms for all beverages were mostly mild. In general, responses to a carbohydrate-rich meal following consumption of S&SE blends with stevia or sucralose were similar to sucrose.

Identifiants

pubmed: 36849009
pii: S0195-6663(23)00068-5
doi: 10.1016/j.appet.2023.106515
pii:
doi:

Substances chimiques

Blood Glucose 0
Cholesterol 97C5T2UQ7J
Sucrose 57-50-1
Sweetening Agents 0

Banques de données

ClinicalTrials.gov
['NCT04483180']

Types de publication

Randomized Controlled Trial Multicenter Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

106515

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest JCGH, JAH, and CAH and are in receipt of research funding from the American Beverage Association; MMR and CEH's research centre provides consultancy to, and has received travel funds to present research results from organisations supported by food and beverage companies. ARA has received honoraria from Nestlé, Unilever and the International Sweeteners Association. CAH has received honoraria from the International Sweeteners Association. CS is an employee of Cargill, Inc. The other authors have nothing to declare.

Auteurs

Eva Almiron-Roig (E)

University of Navarra, Faculty of Pharmacy and Nutrition, Dept. of Food Science and Physiology, Pamplona, Spain; University of Navarra, Center for Nutrition Research, Pamplona, Spain; Navarra Institute for Health Research (IdiSNa), Pamplona, Spain. Electronic address: ealmiron@unav.es.

Santiago Navas-Carretero (S)

University of Navarra, Faculty of Pharmacy and Nutrition, Dept. of Food Science and Physiology, Pamplona, Spain; University of Navarra, Center for Nutrition Research, Pamplona, Spain; Navarra Institute for Health Research (IdiSNa), Pamplona, Spain; Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition (CIBERobn), Institute of Health Carlos III, Madrid, Spain. Electronic address: snavas@unav.es.

Gabriele Castelnuovo (G)

University of Navarra, Center for Nutrition Research, Pamplona, Spain. Electronic address: gabriele.castelnuovo@unito.it.

Louise Kjølbæk (L)

Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark. Electronic address: louisekjoelbaek@nexs.ku.dk.

Ana Romo-Hualde (A)

University of Navarra, Faculty of Pharmacy and Nutrition, Dept. of Food Science and Physiology, Pamplona, Spain; University of Navarra, Center for Nutrition Research, Pamplona, Spain. Electronic address: aromo@unav.es.

Mie Normand (M)

Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark. Electronic address: mino@nexs.ku.dk.

Niamh Maloney (N)

Department of Psychology, University of Liverpool, Liverpool, UK. Electronic address: niamh.maloney@liverpool.ac.uk.

Charlotte A Hardman (CA)

Department of Psychology, University of Liverpool, Liverpool, UK. Electronic address: Charlotte.Hardman@liverpool.ac.uk.

Charo E Hodgkins (CE)

Food Consumer Behaviour and Health Research Centre, School of Psychology, University of Surrey, Guildford, UK. Electronic address: c.hodgkins@surrey.ac.uk.

Hariklia Moshoyiannis (H)

Bioiatriki Healthcare Group, Central Laboratory, Athens, Greece. Electronic address: hmoshoyianni@bioiatriki.gr.

Graham Finlayson (G)

School of Psychology, University of Leeds, Leeds, UK. Electronic address: G.S.Finlayson@leeds.ac.uk.

Corey Scott (C)

Cargill R&D Centre Europe, Vilvoorde, Belgium. Electronic address: Corey_Scott@cargill.com.

Monique M Raats (MM)

Food Consumer Behaviour and Health Research Centre, School of Psychology, University of Surrey, Guildford, UK. Electronic address: m.raats@surrey.ac.uk.

Joanne A Harrold (JA)

Department of Psychology, University of Liverpool, Liverpool, UK. Electronic address: harrold@liverpool.ac.uk.

Anne Raben (A)

Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark; Clinical Research, Copenhagen University Hospital - Steno Diabetes Center Copenhagen, Herlev, Denmark. Electronic address: ara@nexs.ku.dk.

Jason C G Halford (JCG)

Department of Psychology, University of Liverpool, Liverpool, UK; School of Psychology, University of Leeds, Leeds, UK. Electronic address: J.Halford@leeds.ac.uk.

J Alfredo Martínez (JA)

University of Navarra, Faculty of Pharmacy and Nutrition, Dept. of Food Science and Physiology, Pamplona, Spain. Electronic address: jalfmtz@unav.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH